These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8100044)

  • 1. Treatment of the alcoholic organic brain syndrome: double-blind, placebo-controlled clinical, psychometric and electroencephalographic mapping studies with modafinil.
    Saletu B; Saletu M; Grünberger J; Frey R; Anderer P; Mader R
    Neuropsychobiology; 1993; 27(1):26-39. PubMed ID: 8100044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On the treatment of the alcoholic organic brain syndrome with an alpha-adrenergic agonist modafinil: double-blind, placebo-controlled clinical, psychometric and neurophysiological studies.
    Saletu B; Saletu M; Grünberger J; Frey R; Zatschek I; Mader R
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(2):195-214. PubMed ID: 1968672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of a new central adrenergic agonist--modafinil--and D-amphetamine on sleep and early morning behaviour in young healthy volunteers.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ
    Int J Clin Pharmacol Res; 1989; 9(3):183-95. PubMed ID: 2568348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-resolution brain electromagnetic tomography (LORETA) identifies brain regions linked to psychometric performance under modafinil in narcolepsy.
    Saletu M; Anderer P; Semlitsch HV; Saletu-Zyhlarz GM; Mandl M; Zeitlhofer J; Saletu B
    Psychiatry Res; 2007 Jan; 154(1):69-84. PubMed ID: 17187965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spontaneous and drug-induced remission of alcoholic organic brain syndrome: clinical, psychometric, and neurophysiological studies.
    Saletu B; Saletu M; Grünberger J; Mader R
    Psychiatry Res; 1983 Sep; 10(1):59-75. PubMed ID: 6580659
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EEG-mapping differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
    Saletu MT; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Nosiska D; Zeitlhofer J; Saletu B
    Eur Arch Psychiatry Clin Neurosci; 2005 Feb; 255(1):20-32. PubMed ID: 15538594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of modafinil film-coated tablets in children and adolescents with attention-deficit/hyperactivity disorder: results of a randomized, double-blind, placebo-controlled, flexible-dose study.
    Biederman J; Swanson JM; Wigal SB; Kratochvil CJ; Boellner SW; Earl CQ; Jiang J; Greenhill L
    Pediatrics; 2005 Dec; 116(6):e777-84. PubMed ID: 16322134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute central effects of the calcium channel blocker and antiglutamatergic drug caroverine. Double-blind, placebo-controlled, EEG mapping and psychometric studies after intravenous and oral administration.
    Saletu B; Grünberger J; Anderer P; Linzmayer L; König P
    Arzneimittelforschung; 1995 Mar; 45(3):217-29. PubMed ID: 7741773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. EEG-tomographic studies with LORETA on vigilance differences between narcolepsy patients and controls and subsequent double-blind, placebo-controlled studies with modafinil.
    Saletu M; Anderer P; Saletu-Zyhlarz GM; Mandl M; Arnold O; Zeitlhofer J; Saletu B
    J Neurol; 2004 Nov; 251(11):1354-63. PubMed ID: 15592731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of modafinil on impulsivity and relapse in alcohol dependent patients: a randomized, placebo-controlled trial.
    Joos L; Goudriaan AE; Schmaal L; Fransen E; van den Brink W; Sabbe BG; Dom G
    Eur Neuropsychopharmacol; 2013 Aug; 23(8):948-55. PubMed ID: 23141152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral blood flow changes in man by wake-promoting drug, modafinil: a randomized double blind study.
    Joo EY; Tae WS; Jung KY; Hong SB
    J Sleep Res; 2008 Mar; 17(1):82-8. PubMed ID: 18275558
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential effects of the new central adrenergic agonist modafinil and d-amphetamine on sleep and early morning behaviour in elderlies.
    Saletu B; Frey R; Krupka M; Anderer P; Grünberger J; Barbanoj MJ
    Arzneimittelforschung; 1989 Oct; 39(10):1268-73. PubMed ID: 2610719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placebo and modafinil effect on sleepiness in obstructive sleep apnea.
    Bittencourt LR; Lucchesi LM; Rueda AD; Garbuio SA; Palombini LO; Guilleminault C; Tufik S
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):552-9. PubMed ID: 18053628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group.
    Ann Neurol; 1998 Jan; 43(1):88-97. PubMed ID: 9450772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
    Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
    Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Pettinati HM; O'Brien CP
    Neuropsychopharmacology; 2005 Jan; 30(1):205-11. PubMed ID: 15525998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind, placebo-controlled trial of modafinil for cocaine dependence.
    Dackis CA; Kampman KM; Lynch KG; Plebani JG; Pettinati HM; Sparkman T; O'Brien CP
    J Subst Abuse Treat; 2012 Oct; 43(3):303-12. PubMed ID: 22377391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modafinil for the treatment of daytime sleepiness in Parkinson's disease: a double-blind, randomized, crossover, placebo-controlled polygraphic trial.
    Högl B; Saletu M; Brandauer E; Glatzl S; Frauscher B; Seppi K; Ulmer H; Wenning G; Poewe W
    Sleep; 2002 Dec; 25(8):905-9. PubMed ID: 12489899
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modafinil as adjunct therapy for daytime sleepiness in obstructive sleep apnea.
    Pack AI; Black JE; Schwartz JR; Matheson JK
    Am J Respir Crit Care Med; 2001 Nov; 164(9):1675-81. PubMed ID: 11719309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modafinil for excessive sleepiness associated with shift-work sleep disorder.
    Czeisler CA; Walsh JK; Roth T; Hughes RJ; Wright KP; Kingsbury L; Arora S; Schwartz JR; Niebler GE; Dinges DF;
    N Engl J Med; 2005 Aug; 353(5):476-86. PubMed ID: 16079371
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.